Package 72162-2317-9

{"route": ["ORAL"], "spl_id": "6d6fbce6-669e-42e6-9eb9-084756532242", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "unii": ["0J48LPH2TH", "J0E2756Z7N"], "rxcui": ["310792"], "spl_set_id": ["53ce6e4f-db3a-4789-8bef-1e459fa78b79"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (72162-2317-3)", "package_ndc": "72162-2317-3", "marketing_start_date": "20240516"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (72162-2317-9)", "package_ndc": "72162-2317-9", "marketing_start_date": "20240516"}], "brand_name": "Irbesartan and Hydrochlorothiazide", "product_id": "72162-2317_6d6fbce6-669e-42e6-9eb9-084756532242", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "72162-2317", "generic_name": "Irbesartan and Hydrochlorothiazide", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irbesartan and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "IRBESARTAN", "strength": "150 mg/1"}], "application_number": "ANDA203072", "marketing_category": "ANDA", "marketing_start_date": "20140301", "listing_expiration_date": "20261231"}